Schering bundled products subpoena
Executive Summary
Schering-Plough's bundled discounts for seven drugs are the latest target of Boston U.S. Attorney's investigation into company's marketing and clinical trial practices. Schering received a grand jury subpoena in April requesting "documents from certain managed care entities and documents relating to all contracts where the price of one drug is dependent on the purchase of another," the company says an April 28 110-Q filing. Schering received a "target" letter from the Boston U.S. Attorney's office in 2003 (2"The Pink Sheet" June 2, 2003, p. 12)...